An analogous induction of CD8+ Tregs through the presentation of HLA class I tumor antigens, as observed in our data, is possible, and prior ex vivo studies suggest that TCR signaling in KIR+CD8+ Tregs is required for maximal suppressive function2. The gene discussed is KIR3DL1; the disease is neoplasm.